Chi‐Tai Fang
Chi‐Tai Fang publishes mostly in Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health, on topics such as Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria and Antimicrobial Resistance in Staphylococcus.
- World rank
- #760,248 of 7,710,434 ranked researchers
- Rank in Taiwan
- #3,238 of 57,035
- Works
- 222
- Citations
- 9k
- Citations per work
- 40.6
What does Chi‐Tai Fang research?
Chi‐Tai Fang's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11752.9%
- Medicine11752.9%
- Everything else9040.4%
- Life Sciences156.7%
- 1Infectious Diseases26% of their works
- 2Epidemiology17% of their works
- 3Public Health, Environmental and Occupational Health6% of their works
- 4Surgery4% of their works
- 5Molecular Medicine4% of their works
- 6Virology3% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Antibiotic Resistance in Bacteria
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
Which keywords describe Chi‐Tai Fang's research?
The keywords of their largest research topics: Epidemiology, Vaccine, Immune Response, Diagnosis, Treatment, ACE2 Receptor, SARS-CoV-2 and Antimicrobial Resistance.
- Respiratory Syncytial Virus
- Pneumococcal Conjugate Vaccine
- Pneumonia
- Thrombosis
- spike protein
- Staphylococcus aureus
- Multidrug-Resistant Bacteria
- Tuberculosis
- Antimicrobial Resistance
- ACE2 Receptor
- Diagnosis
- Vaccine
- Epidemiology
- Immune Response
- Treatment
- SARS-CoV-2
- Mycobacterium tuberculosis
- Antibiotic Resistance
- MRSA
- Coronavirus
- Clinical Characteristics
- Pneumocystis
- Community-Acquired Pneumonia
- Human Metapneumovirus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Epidemiology1206 topics
- Vaccine532 topics
- Immune Response502 topics
- Diagnosis492 topics
- Treatment492 topics
- ACE2 Receptor392 topics
- SARS-CoV-2392 topics
- Antimicrobial Resistance382 topics
- Mycobacterium tuberculosis321 topic
- Tuberculosis321 topic
- Antibiotic Resistance231 topic
- Multidrug-Resistant Bacteria231 topic
- MRSA221 topic
- Staphylococcus aureus221 topic
- Coronavirus211 topic
- spike protein211 topic
- Clinical Characteristics181 topic
- Thrombosis181 topic
- Pneumocystis171 topic
- Pneumonia171 topic
- Community-Acquired Pneumonia161 topic
- Pneumococcal Conjugate Vaccine161 topic
- Human Metapneumovirus151 topic
- Respiratory Syncytial Virus151 topic
Where does Chi‐Tai Fang work?
Chi‐Tai Fang's main affiliation in the publication record is National Taiwan University Hospital, Taiwan.
How many publications and citations does Chi‐Tai Fang have?
OpenAlex counts 222 works and 9,019 citations for Chi‐Tai Fang, an h-index of 44, ranking #760,248 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chi‐Tai Fang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.